nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—ALB—multiple sclerosis	0.272	1	CbGaD
Rufinamide—CYP2E1—Fingolimod—multiple sclerosis	0.103	0.285	CbGbCtD
Rufinamide—CYP2E1—Mitoxantrone—multiple sclerosis	0.0485	0.134	CbGbCtD
Rufinamide—ALB—Prednisone—multiple sclerosis	0.0389	0.107	CbGbCtD
Rufinamide—CYP3A4—Fingolimod—multiple sclerosis	0.0313	0.0862	CbGbCtD
Rufinamide—CYP2E1—Dexamethasone—multiple sclerosis	0.0251	0.0694	CbGbCtD
Rufinamide—CYP3A4—Methylprednisolone—multiple sclerosis	0.0201	0.0556	CbGbCtD
Rufinamide—ALB—Methotrexate—multiple sclerosis	0.0195	0.0539	CbGbCtD
Rufinamide—SCN3A—spinal nerve—multiple sclerosis	0.0175	0.137	CbGeAlD
Rufinamide—CYP3A4—Triamcinolone—multiple sclerosis	0.0153	0.0421	CbGbCtD
Rufinamide—CYP3A4—Mitoxantrone—multiple sclerosis	0.0147	0.0405	CbGbCtD
Rufinamide—CYP3A4—Betamethasone—multiple sclerosis	0.0131	0.0361	CbGbCtD
Rufinamide—CYP3A4—Prednisolone—multiple sclerosis	0.0129	0.0356	CbGbCtD
Rufinamide—CYP3A4—Prednisone—multiple sclerosis	0.0122	0.0337	CbGbCtD
Rufinamide—SCN11A—peripheral nervous system—multiple sclerosis	0.00938	0.073	CbGeAlD
Rufinamide—CYP3A4—Dexamethasone—multiple sclerosis	0.00762	0.021	CbGbCtD
Rufinamide—SCN11A—nerve—multiple sclerosis	0.00731	0.0569	CbGeAlD
Rufinamide—SCN8A—peripheral nervous system—multiple sclerosis	0.00711	0.0553	CbGeAlD
Rufinamide—SCN8A—nerve—multiple sclerosis	0.00554	0.0431	CbGeAlD
Rufinamide—SCN10A—peripheral nervous system—multiple sclerosis	0.00475	0.037	CbGeAlD
Rufinamide—GRM5—brainstem—multiple sclerosis	0.00423	0.0329	CbGeAlD
Rufinamide—SCN10A—nerve—multiple sclerosis	0.00371	0.0289	CbGeAlD
Rufinamide—GRM5—midbrain—multiple sclerosis	0.00269	0.021	CbGeAlD
Rufinamide—GRM5—spinal cord—multiple sclerosis	0.00263	0.0205	CbGeAlD
Rufinamide—SCN8A—brainstem—multiple sclerosis	0.00238	0.0185	CbGeAlD
Rufinamide—GRM5—nervous system—multiple sclerosis	0.00221	0.0172	CbGeAlD
Rufinamide—GRM5—central nervous system—multiple sclerosis	0.00213	0.0166	CbGeAlD
Rufinamide—GRM5—cerebellum—multiple sclerosis	0.00208	0.0162	CbGeAlD
Rufinamide—SCN11A—spinal cord—multiple sclerosis	0.00195	0.0152	CbGeAlD
Rufinamide—SCN1A—brainstem—multiple sclerosis	0.0018	0.014	CbGeAlD
Rufinamide—GRM5—brain—multiple sclerosis	0.00169	0.0132	CbGeAlD
Rufinamide—SCN2A—brainstem—multiple sclerosis	0.00165	0.0128	CbGeAlD
Rufinamide—SCN11A—nervous system—multiple sclerosis	0.00164	0.0128	CbGeAlD
Rufinamide—SCN11A—central nervous system—multiple sclerosis	0.00158	0.0123	CbGeAlD
Rufinamide—SCN8A—spinal cord—multiple sclerosis	0.00148	0.0115	CbGeAlD
Rufinamide—SCN9A—midbrain—multiple sclerosis	0.00133	0.0104	CbGeAlD
Rufinamide—SCN9A—spinal cord—multiple sclerosis	0.0013	0.0101	CbGeAlD
Rufinamide—SCN11A—brain—multiple sclerosis	0.00126	0.00978	CbGeAlD
Rufinamide—SCN1A—medulla oblongata—multiple sclerosis	0.00125	0.00976	CbGeAlD
Rufinamide—SCN8A—nervous system—multiple sclerosis	0.00125	0.0097	CbGeAlD
Rufinamide—SCN8A—central nervous system—multiple sclerosis	0.0012	0.00934	CbGeAlD
Rufinamide—SCN8A—cerebellum—multiple sclerosis	0.00117	0.00913	CbGeAlD
Rufinamide—SCN2A—medulla oblongata—multiple sclerosis	0.00115	0.00896	CbGeAlD
Rufinamide—SCN1A—midbrain—multiple sclerosis	0.00115	0.00892	CbGeAlD
Rufinamide—SCN1A—spinal cord—multiple sclerosis	0.00112	0.0087	CbGeAlD
Rufinamide—SCN7A—brain—multiple sclerosis	0.00107	0.00832	CbGeAlD
Rufinamide—SCN2A—midbrain—multiple sclerosis	0.00105	0.00819	CbGeAlD
Rufinamide—SCN2A—spinal cord—multiple sclerosis	0.00103	0.00799	CbGeAlD
Rufinamide—SCN3A—medulla oblongata—multiple sclerosis	0.00101	0.00787	CbGeAlD
Rufinamide—SCN10A—spinal cord—multiple sclerosis	0.000989	0.0077	CbGeAlD
Rufinamide—SCN4A—nervous system—multiple sclerosis	0.000977	0.0076	CbGeAlD
Rufinamide—SCN8A—brain—multiple sclerosis	0.000952	0.00741	CbGeAlD
Rufinamide—SCN1A—nervous system—multiple sclerosis	0.000942	0.00733	CbGeAlD
Rufinamide—SCN4A—central nervous system—multiple sclerosis	0.00094	0.00732	CbGeAlD
Rufinamide—SCN3A—midbrain—multiple sclerosis	0.000924	0.00719	CbGeAlD
Rufinamide—SCN1A—central nervous system—multiple sclerosis	0.000907	0.00706	CbGeAlD
Rufinamide—SCN3A—spinal cord—multiple sclerosis	0.000902	0.00702	CbGeAlD
Rufinamide—SCN1A—cerebellum—multiple sclerosis	0.000886	0.0069	CbGeAlD
Rufinamide—CES1—nervous system—multiple sclerosis	0.000872	0.00679	CbGeAlD
Rufinamide—SCN2A—nervous system—multiple sclerosis	0.000865	0.00673	CbGeAlD
Rufinamide—CES1—central nervous system—multiple sclerosis	0.00084	0.00654	CbGeAlD
Rufinamide—SCN9A—brain—multiple sclerosis	0.000837	0.00651	CbGeAlD
Rufinamide—SCN10A—nervous system—multiple sclerosis	0.000834	0.00649	CbGeAlD
Rufinamide—SCN2A—central nervous system—multiple sclerosis	0.000832	0.00648	CbGeAlD
Rufinamide—SCN2A—cerebellum—multiple sclerosis	0.000814	0.00633	CbGeAlD
Rufinamide—SCN10A—central nervous system—multiple sclerosis	0.000803	0.00625	CbGeAlD
Rufinamide—SCN3A—nervous system—multiple sclerosis	0.00076	0.00591	CbGeAlD
Rufinamide—SCN5A—nervous system—multiple sclerosis	0.000758	0.0059	CbGeAlD
Rufinamide—SCN4A—brain—multiple sclerosis	0.000747	0.00581	CbGeAlD
Rufinamide—SCN3A—central nervous system—multiple sclerosis	0.000732	0.00569	CbGeAlD
Rufinamide—SCN5A—central nervous system—multiple sclerosis	0.000729	0.00568	CbGeAlD
Rufinamide—SCN1A—brain—multiple sclerosis	0.00072	0.0056	CbGeAlD
Rufinamide—SCN3A—cerebellum—multiple sclerosis	0.000715	0.00557	CbGeAlD
Rufinamide—CES1—brain—multiple sclerosis	0.000667	0.00519	CbGeAlD
Rufinamide—SCN2A—brain—multiple sclerosis	0.000661	0.00514	CbGeAlD
Rufinamide—SCN10A—brain—multiple sclerosis	0.000637	0.00496	CbGeAlD
Rufinamide—SCN3A—brain—multiple sclerosis	0.000581	0.00452	CbGeAlD
Rufinamide—SCN5A—brain—multiple sclerosis	0.000579	0.00451	CbGeAlD
Rufinamide—Nervous system disorder—Cladribine—multiple sclerosis	0.000507	0.00361	CcSEcCtD
Rufinamide—Thrombocytopenia—Cladribine—multiple sclerosis	0.000506	0.0036	CcSEcCtD
Rufinamide—Increased appetite—Dexamethasone—multiple sclerosis	0.000504	0.00358	CcSEcCtD
Rufinamide—Increased appetite—Betamethasone—multiple sclerosis	0.000504	0.00358	CcSEcCtD
Rufinamide—Skin disorder—Cladribine—multiple sclerosis	0.000502	0.00357	CcSEcCtD
Rufinamide—Sinusitis—Mitoxantrone—multiple sclerosis	0.0005	0.00356	CcSEcCtD
Rufinamide—Anorexia—Cladribine—multiple sclerosis	0.000493	0.00351	CcSEcCtD
Rufinamide—Rhinitis—Mitoxantrone—multiple sclerosis	0.000479	0.00341	CcSEcCtD
Rufinamide—CYP2E1—medulla oblongata—multiple sclerosis	0.000478	0.00372	CbGeAlD
Rufinamide—Anaemia—Azathioprine—multiple sclerosis	0.000476	0.00339	CcSEcCtD
Rufinamide—Breast disorder—Methylprednisolone—multiple sclerosis	0.00047	0.00335	CcSEcCtD
Rufinamide—Insomnia—Cladribine—multiple sclerosis	0.000467	0.00333	CcSEcCtD
Rufinamide—ALB—brain—multiple sclerosis	0.000464	0.00361	CbGeAlD
Rufinamide—Leukopenia—Azathioprine—multiple sclerosis	0.000461	0.00328	CcSEcCtD
Rufinamide—Somnolence—Cladribine—multiple sclerosis	0.000459	0.00327	CcSEcCtD
Rufinamide—Influenza—Triamcinolone—multiple sclerosis	0.000451	0.00321	CcSEcCtD
Rufinamide—Decreased appetite—Cladribine—multiple sclerosis	0.000449	0.0032	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000446	0.00317	CcSEcCtD
Rufinamide—Fatigue—Cladribine—multiple sclerosis	0.000446	0.00317	CcSEcCtD
Rufinamide—Constipation—Cladribine—multiple sclerosis	0.000442	0.00314	CcSEcCtD
Rufinamide—Increased appetite—Prednisone—multiple sclerosis	0.000439	0.00312	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000435	0.0031	CcSEcCtD
Rufinamide—Bronchitis—Triamcinolone—multiple sclerosis	0.000433	0.00308	CcSEcCtD
Rufinamide—Urine output increased—Methotrexate—multiple sclerosis	0.000429	0.00305	CcSEcCtD
Rufinamide—CYP2E1—spinal cord—multiple sclerosis	0.000426	0.00331	CbGeAlD
Rufinamide—Infection—Azathioprine—multiple sclerosis	0.000417	0.00297	CcSEcCtD
Rufinamide—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000411	0.00293	CcSEcCtD
Rufinamide—Skin disorder—Azathioprine—multiple sclerosis	0.000408	0.0029	CcSEcCtD
Rufinamide—Lymphadenopathy—Methotrexate—multiple sclerosis	0.000404	0.00287	CcSEcCtD
Rufinamide—Back pain—Mitoxantrone—multiple sclerosis	0.000403	0.00286	CcSEcCtD
Rufinamide—Infestation NOS—Methylprednisolone—multiple sclerosis	0.000401	0.00285	CcSEcCtD
Rufinamide—Infestation—Methylprednisolone—multiple sclerosis	0.000401	0.00285	CcSEcCtD
Rufinamide—Vision blurred—Mitoxantrone—multiple sclerosis	0.000392	0.00279	CcSEcCtD
Rufinamide—Polyuria—Methotrexate—multiple sclerosis	0.000392	0.00279	CcSEcCtD
Rufinamide—Anaemia—Mitoxantrone—multiple sclerosis	0.000385	0.00274	CcSEcCtD
Rufinamide—Hypersensitivity—Cladribine—multiple sclerosis	0.000381	0.00271	CcSEcCtD
Rufinamide—Epistaxis—Triamcinolone—multiple sclerosis	0.000379	0.0027	CcSEcCtD
Rufinamide—Leukopenia—Mitoxantrone—multiple sclerosis	0.000373	0.00265	CcSEcCtD
Rufinamide—Asthenia—Cladribine—multiple sclerosis	0.000371	0.00264	CcSEcCtD
Rufinamide—Weight decreased—Betamethasone—multiple sclerosis	0.00037	0.00263	CcSEcCtD
Rufinamide—Weight decreased—Dexamethasone—multiple sclerosis	0.00037	0.00263	CcSEcCtD
Rufinamide—Pruritus—Cladribine—multiple sclerosis	0.000366	0.0026	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000363	0.00258	CcSEcCtD
Rufinamide—Rhinitis—Triamcinolone—multiple sclerosis	0.000362	0.00257	CcSEcCtD
Rufinamide—Rhinitis—Methylprednisolone—multiple sclerosis	0.000361	0.00257	CcSEcCtD
Rufinamide—Convulsion—Mitoxantrone—multiple sclerosis	0.000361	0.00257	CcSEcCtD
Rufinamide—CYP2E1—nervous system—multiple sclerosis	0.000359	0.00279	CbGeAlD
Rufinamide—Diarrhoea—Cladribine—multiple sclerosis	0.000354	0.00252	CcSEcCtD
Rufinamide—Anxiety—Mitoxantrone—multiple sclerosis	0.000353	0.00251	CcSEcCtD
Rufinamide—CYP2E1—central nervous system—multiple sclerosis	0.000345	0.00269	CbGeAlD
Rufinamide—Dizziness—Cladribine—multiple sclerosis	0.000342	0.00243	CcSEcCtD
Rufinamide—CYP2E1—cerebellum—multiple sclerosis	0.000338	0.00263	CbGeAlD
Rufinamide—Infection—Mitoxantrone—multiple sclerosis	0.000337	0.0024	CcSEcCtD
Rufinamide—Eye disorder—Methylprednisolone—multiple sclerosis	0.000336	0.00239	CcSEcCtD
Rufinamide—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000334	0.00238	CcSEcCtD
Rufinamide—Neutropenia—Prednisone—multiple sclerosis	0.000333	0.00237	CcSEcCtD
Rufinamide—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000333	0.00237	CcSEcCtD
Rufinamide—Skin disorder—Mitoxantrone—multiple sclerosis	0.00033	0.00235	CcSEcCtD
Rufinamide—Vomiting—Cladribine—multiple sclerosis	0.000329	0.00234	CcSEcCtD
Rufinamide—Rash—Cladribine—multiple sclerosis	0.000326	0.00232	CcSEcCtD
Rufinamide—Dermatitis—Cladribine—multiple sclerosis	0.000326	0.00232	CcSEcCtD
Rufinamide—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000325	0.00231	CcSEcCtD
Rufinamide—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000324	0.00231	CcSEcCtD
Rufinamide—Anorexia—Mitoxantrone—multiple sclerosis	0.000324	0.0023	CcSEcCtD
Rufinamide—Ataxia—Methotrexate—multiple sclerosis	0.000324	0.0023	CcSEcCtD
Rufinamide—Headache—Cladribine—multiple sclerosis	0.000324	0.0023	CcSEcCtD
Rufinamide—Weight decreased—Prednisone—multiple sclerosis	0.000322	0.00229	CcSEcCtD
Rufinamide—Vision blurred—Prednisolone—multiple sclerosis	0.000322	0.00229	CcSEcCtD
Rufinamide—Mental disorder—Methylprednisolone—multiple sclerosis	0.000315	0.00224	CcSEcCtD
Rufinamide—Malnutrition—Methylprednisolone—multiple sclerosis	0.000313	0.00223	CcSEcCtD
Rufinamide—Breast disorder—Methotrexate—multiple sclerosis	0.000311	0.00221	CcSEcCtD
Rufinamide—Hypersensitivity—Azathioprine—multiple sclerosis	0.00031	0.0022	CcSEcCtD
Rufinamide—Nausea—Cladribine—multiple sclerosis	0.000307	0.00218	CcSEcCtD
Rufinamide—Vertigo—Prednisolone—multiple sclerosis	0.000307	0.00218	CcSEcCtD
Rufinamide—Eye disorder—Betamethasone—multiple sclerosis	0.000306	0.00218	CcSEcCtD
Rufinamide—Eye disorder—Dexamethasone—multiple sclerosis	0.000306	0.00218	CcSEcCtD
Rufinamide—Back pain—Triamcinolone—multiple sclerosis	0.000304	0.00216	CcSEcCtD
Rufinamide—Somnolence—Mitoxantrone—multiple sclerosis	0.000302	0.00215	CcSEcCtD
Rufinamide—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000299	0.00213	CcSEcCtD
Rufinamide—Convulsion—Prednisolone—multiple sclerosis	0.000296	0.00211	CcSEcCtD
Rufinamide—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000295	0.0021	CcSEcCtD
Rufinamide—Fatigue—Mitoxantrone—multiple sclerosis	0.000293	0.00208	CcSEcCtD
Rufinamide—Constipation—Mitoxantrone—multiple sclerosis	0.00029	0.00207	CcSEcCtD
Rufinamide—CYP3A4—nervous system—multiple sclerosis	0.000289	0.00225	CbGeAlD
Rufinamide—Diarrhoea—Azathioprine—multiple sclerosis	0.000287	0.00205	CcSEcCtD
Rufinamide—Vertigo—Triamcinolone—multiple sclerosis	0.000282	0.00201	CcSEcCtD
Rufinamide—Vertigo—Methylprednisolone—multiple sclerosis	0.000281	0.002	CcSEcCtD
Rufinamide—Dysuria—Methotrexate—multiple sclerosis	0.000278	0.00198	CcSEcCtD
Rufinamide—Neutropenia—Methotrexate—multiple sclerosis	0.000278	0.00198	CcSEcCtD
Rufinamide—CYP3A4—central nervous system—multiple sclerosis	0.000278	0.00216	CbGeAlD
Rufinamide—Dizziness—Azathioprine—multiple sclerosis	0.000278	0.00198	CcSEcCtD
Rufinamide—CYP2E1—brain—multiple sclerosis	0.000274	0.00213	CbGeAlD
Rufinamide—Convulsion—Triamcinolone—multiple sclerosis	0.000272	0.00194	CcSEcCtD
Rufinamide—Convulsion—Methylprednisolone—multiple sclerosis	0.000271	0.00193	CcSEcCtD
Rufinamide—Vomiting—Azathioprine—multiple sclerosis	0.000267	0.0019	CcSEcCtD
Rufinamide—Pneumonia—Methotrexate—multiple sclerosis	0.000267	0.0019	CcSEcCtD
Rufinamide—Eye disorder—Prednisone—multiple sclerosis	0.000266	0.0019	CcSEcCtD
Rufinamide—Anxiety—Methylprednisolone—multiple sclerosis	0.000266	0.00189	CcSEcCtD
Rufinamide—Infestation NOS—Methotrexate—multiple sclerosis	0.000265	0.00189	CcSEcCtD
Rufinamide—Infestation—Methotrexate—multiple sclerosis	0.000265	0.00189	CcSEcCtD
Rufinamide—Rash—Azathioprine—multiple sclerosis	0.000265	0.00189	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000265	0.00189	CcSEcCtD
Rufinamide—Dermatitis—Azathioprine—multiple sclerosis	0.000265	0.00188	CcSEcCtD
Rufinamide—Headache—Azathioprine—multiple sclerosis	0.000263	0.00187	CcSEcCtD
Rufinamide—Immune system disorder—Prednisone—multiple sclerosis	0.000257	0.00183	CcSEcCtD
Rufinamide—Vertigo—Dexamethasone—multiple sclerosis	0.000256	0.00182	CcSEcCtD
Rufinamide—Vertigo—Betamethasone—multiple sclerosis	0.000256	0.00182	CcSEcCtD
Rufinamide—Infection—Triamcinolone—multiple sclerosis	0.000255	0.00181	CcSEcCtD
Rufinamide—Infection—Methylprednisolone—multiple sclerosis	0.000254	0.00181	CcSEcCtD
Rufinamide—Haematuria—Methotrexate—multiple sclerosis	0.000253	0.0018	CcSEcCtD
Rufinamide—Insomnia—Prednisolone—multiple sclerosis	0.000252	0.00179	CcSEcCtD
Rufinamide—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000251	0.00179	CcSEcCtD
Rufinamide—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000251	0.00178	CcSEcCtD
Rufinamide—Epistaxis—Methotrexate—multiple sclerosis	0.00025	0.00178	CcSEcCtD
Rufinamide—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00025	0.00178	CcSEcCtD
Rufinamide—Mental disorder—Prednisone—multiple sclerosis	0.00025	0.00178	CcSEcCtD
Rufinamide—Nausea—Azathioprine—multiple sclerosis	0.00025	0.00178	CcSEcCtD
Rufinamide—Skin disorder—Methylprednisolone—multiple sclerosis	0.000248	0.00177	CcSEcCtD
Rufinamide—Malnutrition—Prednisone—multiple sclerosis	0.000248	0.00177	CcSEcCtD
Rufinamide—Convulsion—Dexamethasone—multiple sclerosis	0.000247	0.00176	CcSEcCtD
Rufinamide—Convulsion—Betamethasone—multiple sclerosis	0.000247	0.00176	CcSEcCtD
Rufinamide—Asthenia—Mitoxantrone—multiple sclerosis	0.000244	0.00173	CcSEcCtD
Rufinamide—Anxiety—Betamethasone—multiple sclerosis	0.000242	0.00172	CcSEcCtD
Rufinamide—Anxiety—Dexamethasone—multiple sclerosis	0.000242	0.00172	CcSEcCtD
Rufinamide—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000235	0.00167	CcSEcCtD
Rufinamide—Vision blurred—Prednisone—multiple sclerosis	0.000234	0.00166	CcSEcCtD
Rufinamide—Urethral disorder—Methotrexate—multiple sclerosis	0.000234	0.00166	CcSEcCtD
Rufinamide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000232	0.00165	CcSEcCtD
Rufinamide—Insomnia—Triamcinolone—multiple sclerosis	0.000232	0.00165	CcSEcCtD
Rufinamide—Insomnia—Methylprednisolone—multiple sclerosis	0.000231	0.00165	CcSEcCtD
Rufinamide—Infection—Betamethasone—multiple sclerosis	0.000231	0.00164	CcSEcCtD
Rufinamide—Infection—Dexamethasone—multiple sclerosis	0.000231	0.00164	CcSEcCtD
Rufinamide—Anaemia—Prednisone—multiple sclerosis	0.000229	0.00163	CcSEcCtD
Rufinamide—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000228	0.00162	CcSEcCtD
Rufinamide—Nervous system disorder—Betamethasone—multiple sclerosis	0.000228	0.00162	CcSEcCtD
Rufinamide—Agitation—Prednisone—multiple sclerosis	0.000228	0.00162	CcSEcCtD
Rufinamide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000228	0.00162	CcSEcCtD
Rufinamide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000228	0.00162	CcSEcCtD
Rufinamide—Dyspepsia—Triamcinolone—multiple sclerosis	0.000226	0.00161	CcSEcCtD
Rufinamide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000225	0.0016	CcSEcCtD
Rufinamide—Vertigo—Prednisone—multiple sclerosis	0.000223	0.00159	CcSEcCtD
Rufinamide—Eye disorder—Methotrexate—multiple sclerosis	0.000223	0.00158	CcSEcCtD
Rufinamide—Anorexia—Betamethasone—multiple sclerosis	0.000222	0.00158	CcSEcCtD
Rufinamide—Anorexia—Dexamethasone—multiple sclerosis	0.000222	0.00158	CcSEcCtD
Rufinamide—Cardiac disorder—Methotrexate—multiple sclerosis	0.000221	0.00157	CcSEcCtD
Rufinamide—Fatigue—Triamcinolone—multiple sclerosis	0.000221	0.00157	CcSEcCtD
Rufinamide—Fatigue—Methylprednisolone—multiple sclerosis	0.00022	0.00157	CcSEcCtD
Rufinamide—Vomiting—Mitoxantrone—multiple sclerosis	0.000216	0.00154	CcSEcCtD
Rufinamide—Immune system disorder—Methotrexate—multiple sclerosis	0.000215	0.00153	CcSEcCtD
Rufinamide—Convulsion—Prednisone—multiple sclerosis	0.000215	0.00153	CcSEcCtD
Rufinamide—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000215	0.00153	CcSEcCtD
Rufinamide—Rash—Mitoxantrone—multiple sclerosis	0.000214	0.00152	CcSEcCtD
Rufinamide—Dermatitis—Mitoxantrone—multiple sclerosis	0.000214	0.00152	CcSEcCtD
Rufinamide—Headache—Mitoxantrone—multiple sclerosis	0.000213	0.00151	CcSEcCtD
Rufinamide—Anxiety—Prednisone—multiple sclerosis	0.000211	0.0015	CcSEcCtD
Rufinamide—Insomnia—Betamethasone—multiple sclerosis	0.00021	0.0015	CcSEcCtD
Rufinamide—Insomnia—Dexamethasone—multiple sclerosis	0.00021	0.0015	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00021	0.00149	CcSEcCtD
Rufinamide—Mental disorder—Methotrexate—multiple sclerosis	0.000209	0.00149	CcSEcCtD
Rufinamide—Malnutrition—Methotrexate—multiple sclerosis	0.000207	0.00148	CcSEcCtD
Rufinamide—Hypersensitivity—Prednisolone—multiple sclerosis	0.000205	0.00146	CcSEcCtD
Rufinamide—Dyspepsia—Betamethasone—multiple sclerosis	0.000205	0.00146	CcSEcCtD
Rufinamide—Dyspepsia—Dexamethasone—multiple sclerosis	0.000205	0.00146	CcSEcCtD
Rufinamide—Decreased appetite—Dexamethasone—multiple sclerosis	0.000202	0.00144	CcSEcCtD
Rufinamide—Decreased appetite—Betamethasone—multiple sclerosis	0.000202	0.00144	CcSEcCtD
Rufinamide—Nausea—Mitoxantrone—multiple sclerosis	0.000202	0.00144	CcSEcCtD
Rufinamide—Infection—Prednisone—multiple sclerosis	0.000201	0.00143	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000201	0.00143	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000201	0.00143	CcSEcCtD
Rufinamide—Back pain—Methotrexate—multiple sclerosis	0.000201	0.00143	CcSEcCtD
Rufinamide—Fatigue—Dexamethasone—multiple sclerosis	0.0002	0.00143	CcSEcCtD
Rufinamide—Fatigue—Betamethasone—multiple sclerosis	0.0002	0.00143	CcSEcCtD
Rufinamide—Nervous system disorder—Prednisone—multiple sclerosis	0.000199	0.00141	CcSEcCtD
Rufinamide—Skin disorder—Prednisone—multiple sclerosis	0.000197	0.0014	CcSEcCtD
Rufinamide—Vision blurred—Methotrexate—multiple sclerosis	0.000195	0.00139	CcSEcCtD
Rufinamide—Anorexia—Prednisone—multiple sclerosis	0.000193	0.00137	CcSEcCtD
Rufinamide—Anaemia—Methotrexate—multiple sclerosis	0.000192	0.00136	CcSEcCtD
Rufinamide—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000189	0.00134	CcSEcCtD
Rufinamide—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000188	0.00134	CcSEcCtD
Rufinamide—Vertigo—Methotrexate—multiple sclerosis	0.000186	0.00133	CcSEcCtD
Rufinamide—Leukopenia—Methotrexate—multiple sclerosis	0.000186	0.00132	CcSEcCtD
Rufinamide—Dizziness—Prednisolone—multiple sclerosis	0.000184	0.00131	CcSEcCtD
Rufinamide—Asthenia—Triamcinolone—multiple sclerosis	0.000184	0.00131	CcSEcCtD
Rufinamide—Asthenia—Methylprednisolone—multiple sclerosis	0.000183	0.00131	CcSEcCtD
Rufinamide—Insomnia—Prednisone—multiple sclerosis	0.000183	0.0013	CcSEcCtD
Rufinamide—Pruritus—Triamcinolone—multiple sclerosis	0.000181	0.00129	CcSEcCtD
Rufinamide—Pruritus—Methylprednisolone—multiple sclerosis	0.000181	0.00129	CcSEcCtD
Rufinamide—Convulsion—Methotrexate—multiple sclerosis	0.00018	0.00128	CcSEcCtD
Rufinamide—Dyspepsia—Prednisone—multiple sclerosis	0.000178	0.00127	CcSEcCtD
Rufinamide—Decreased appetite—Prednisone—multiple sclerosis	0.000176	0.00125	CcSEcCtD
Rufinamide—Rash—Prednisolone—multiple sclerosis	0.000176	0.00125	CcSEcCtD
Rufinamide—Dermatitis—Prednisolone—multiple sclerosis	0.000176	0.00125	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000175	0.00125	CcSEcCtD
Rufinamide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000175	0.00124	CcSEcCtD
Rufinamide—Fatigue—Prednisone—multiple sclerosis	0.000175	0.00124	CcSEcCtD
Rufinamide—Headache—Prednisolone—multiple sclerosis	0.000175	0.00124	CcSEcCtD
Rufinamide—Constipation—Prednisone—multiple sclerosis	0.000173	0.00123	CcSEcCtD
Rufinamide—Dizziness—Triamcinolone—multiple sclerosis	0.000169	0.00121	CcSEcCtD
Rufinamide—Dizziness—Methylprednisolone—multiple sclerosis	0.000169	0.0012	CcSEcCtD
Rufinamide—Infection—Methotrexate—multiple sclerosis	0.000168	0.0012	CcSEcCtD
Rufinamide—Asthenia—Dexamethasone—multiple sclerosis	0.000167	0.00119	CcSEcCtD
Rufinamide—Asthenia—Betamethasone—multiple sclerosis	0.000167	0.00119	CcSEcCtD
Rufinamide—Nervous system disorder—Methotrexate—multiple sclerosis	0.000166	0.00118	CcSEcCtD
Rufinamide—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000166	0.00118	CcSEcCtD
Rufinamide—Nausea—Prednisolone—multiple sclerosis	0.000166	0.00118	CcSEcCtD
Rufinamide—Pruritus—Dexamethasone—multiple sclerosis	0.000165	0.00117	CcSEcCtD
Rufinamide—Pruritus—Betamethasone—multiple sclerosis	0.000165	0.00117	CcSEcCtD
Rufinamide—Skin disorder—Methotrexate—multiple sclerosis	0.000164	0.00117	CcSEcCtD
Rufinamide—Vomiting—Triamcinolone—multiple sclerosis	0.000163	0.00116	CcSEcCtD
Rufinamide—Vomiting—Methylprednisolone—multiple sclerosis	0.000163	0.00116	CcSEcCtD
Rufinamide—Rash—Triamcinolone—multiple sclerosis	0.000162	0.00115	CcSEcCtD
Rufinamide—Dermatitis—Triamcinolone—multiple sclerosis	0.000161	0.00115	CcSEcCtD
Rufinamide—Anorexia—Methotrexate—multiple sclerosis	0.000161	0.00115	CcSEcCtD
Rufinamide—Rash—Methylprednisolone—multiple sclerosis	0.000161	0.00115	CcSEcCtD
Rufinamide—Dermatitis—Methylprednisolone—multiple sclerosis	0.000161	0.00115	CcSEcCtD
Rufinamide—Headache—Triamcinolone—multiple sclerosis	0.000161	0.00114	CcSEcCtD
Rufinamide—Headache—Methylprednisolone—multiple sclerosis	0.00016	0.00114	CcSEcCtD
Rufinamide—Diarrhoea—Betamethasone—multiple sclerosis	0.000159	0.00113	CcSEcCtD
Rufinamide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000159	0.00113	CcSEcCtD
Rufinamide—Dizziness—Betamethasone—multiple sclerosis	0.000154	0.00109	CcSEcCtD
Rufinamide—Dizziness—Dexamethasone—multiple sclerosis	0.000154	0.00109	CcSEcCtD
Rufinamide—Insomnia—Methotrexate—multiple sclerosis	0.000153	0.00109	CcSEcCtD
Rufinamide—Nausea—Triamcinolone—multiple sclerosis	0.000152	0.00108	CcSEcCtD
Rufinamide—Nausea—Methylprednisolone—multiple sclerosis	0.000152	0.00108	CcSEcCtD
Rufinamide—Somnolence—Methotrexate—multiple sclerosis	0.00015	0.00107	CcSEcCtD
Rufinamide—Hypersensitivity—Prednisone—multiple sclerosis	0.000149	0.00106	CcSEcCtD
Rufinamide—Dyspepsia—Methotrexate—multiple sclerosis	0.000149	0.00106	CcSEcCtD
Rufinamide—Vomiting—Dexamethasone—multiple sclerosis	0.000148	0.00105	CcSEcCtD
Rufinamide—Vomiting—Betamethasone—multiple sclerosis	0.000148	0.00105	CcSEcCtD
Rufinamide—Decreased appetite—Methotrexate—multiple sclerosis	0.000147	0.00105	CcSEcCtD
Rufinamide—Rash—Betamethasone—multiple sclerosis	0.000147	0.00104	CcSEcCtD
Rufinamide—Rash—Dexamethasone—multiple sclerosis	0.000147	0.00104	CcSEcCtD
Rufinamide—Dermatitis—Dexamethasone—multiple sclerosis	0.000146	0.00104	CcSEcCtD
Rufinamide—Dermatitis—Betamethasone—multiple sclerosis	0.000146	0.00104	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000146	0.00104	CcSEcCtD
Rufinamide—Fatigue—Methotrexate—multiple sclerosis	0.000146	0.00104	CcSEcCtD
Rufinamide—Headache—Betamethasone—multiple sclerosis	0.000146	0.00104	CcSEcCtD
Rufinamide—Headache—Dexamethasone—multiple sclerosis	0.000146	0.00104	CcSEcCtD
Rufinamide—Asthenia—Prednisone—multiple sclerosis	0.000145	0.00103	CcSEcCtD
Rufinamide—Pruritus—Prednisone—multiple sclerosis	0.000143	0.00102	CcSEcCtD
Rufinamide—Diarrhoea—Prednisone—multiple sclerosis	0.000139	0.000986	CcSEcCtD
Rufinamide—Nausea—Dexamethasone—multiple sclerosis	0.000138	0.000983	CcSEcCtD
Rufinamide—Nausea—Betamethasone—multiple sclerosis	0.000138	0.000983	CcSEcCtD
Rufinamide—Dizziness—Prednisone—multiple sclerosis	0.000134	0.000953	CcSEcCtD
Rufinamide—GRM5—Signaling Pathways—CXCL13—multiple sclerosis	0.000129	0.00133	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCR1—multiple sclerosis	0.000129	0.00133	CbGpPWpGaD
Rufinamide—Vomiting—Prednisone—multiple sclerosis	0.000129	0.000916	CcSEcCtD
Rufinamide—GRM5—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000129	0.00133	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—PTPRC—multiple sclerosis	0.000128	0.00132	CbGpPWpGaD
Rufinamide—Rash—Prednisone—multiple sclerosis	0.000128	0.000909	CcSEcCtD
Rufinamide—Dermatitis—Prednisone—multiple sclerosis	0.000128	0.000908	CcSEcCtD
Rufinamide—Headache—Prednisone—multiple sclerosis	0.000127	0.000903	CcSEcCtD
Rufinamide—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	0.000126	0.0013	CbGpPWpGaD
Rufinamide—Hypersensitivity—Methotrexate—multiple sclerosis	0.000125	0.000887	CcSEcCtD
Rufinamide—SCN11A—Axon guidance—TYK2—multiple sclerosis	0.000124	0.00129	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	0.000124	0.00128	CbGpPWpGaD
Rufinamide—Asthenia—Methotrexate—multiple sclerosis	0.000121	0.000864	CcSEcCtD
Rufinamide—Nausea—Prednisone—multiple sclerosis	0.00012	0.000856	CcSEcCtD
Rufinamide—Pruritus—Methotrexate—multiple sclerosis	0.00012	0.000852	CcSEcCtD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.00012	0.00124	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IL4—multiple sclerosis	0.000119	0.00124	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—PRNP—multiple sclerosis	0.000117	0.00121	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—CXCL10—multiple sclerosis	0.000117	0.00121	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	0.000117	0.00121	CbGpPWpGaD
Rufinamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000116	0.0012	CbGpPWpGaD
Rufinamide—Diarrhoea—Methotrexate—multiple sclerosis	0.000116	0.000824	CcSEcCtD
Rufinamide—SCN8A—Axon guidance—TYK2—multiple sclerosis	0.000114	0.00118	CbGpPWpGaD
Rufinamide—Dizziness—Methotrexate—multiple sclerosis	0.000112	0.000796	CcSEcCtD
Rufinamide—GRM5—GPCR downstream signaling—CCL5—multiple sclerosis	0.000111	0.00114	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—MMP9—multiple sclerosis	0.00011	0.00114	CbGpPWpGaD
Rufinamide—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000109	0.00113	CbGpPWpGaD
Rufinamide—CES1—NRF2 pathway—TGFB1—multiple sclerosis	0.000109	0.00112	CbGpPWpGaD
Rufinamide—Vomiting—Methotrexate—multiple sclerosis	0.000108	0.000766	CcSEcCtD
Rufinamide—Rash—Methotrexate—multiple sclerosis	0.000107	0.000759	CcSEcCtD
Rufinamide—Dermatitis—Methotrexate—multiple sclerosis	0.000107	0.000759	CcSEcCtD
Rufinamide—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000106	0.0011	CbGpPWpGaD
Rufinamide—Headache—Methotrexate—multiple sclerosis	0.000106	0.000754	CcSEcCtD
Rufinamide—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000105	0.00109	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	0.000104	0.00108	CbGpPWpGaD
Rufinamide—Nausea—Methotrexate—multiple sclerosis	0.000101	0.000715	CcSEcCtD
Rufinamide—GRM5—Signaling by GPCR—CCL5—multiple sclerosis	0.0001	0.00104	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SELPLG—multiple sclerosis	9.98e-05	0.00103	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MERTK—multiple sclerosis	9.98e-05	0.00103	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CD58—multiple sclerosis	9.98e-05	0.00103	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—CCR5—multiple sclerosis	9.97e-05	0.00103	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—TYK2—multiple sclerosis	9.95e-05	0.00103	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—IL2RA—multiple sclerosis	9.82e-05	0.00102	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—MMP9—multiple sclerosis	9.79e-05	0.00101	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	9.68e-05	0.001	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	9.68e-05	0.001	CbGpPWpGaD
Rufinamide—SCN5A—L1CAM interactions—MAPK1—multiple sclerosis	9.65e-05	0.000997	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.55e-05	0.000987	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.55e-05	0.000987	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—ICAM1—multiple sclerosis	9.49e-05	0.000982	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—TYK2—multiple sclerosis	9.19e-05	0.000951	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCL3—multiple sclerosis	9.18e-05	0.000949	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—PTPRC—multiple sclerosis	9.13e-05	0.000944	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—CCR5—multiple sclerosis	9.05e-05	0.000936	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—MMP9—multiple sclerosis	8.95e-05	0.000926	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—IL2RA—multiple sclerosis	8.92e-05	0.000922	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	8.88e-05	0.000918	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—MAPK1—multiple sclerosis	8.88e-05	0.000918	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—TYK2—multiple sclerosis	8.87e-05	0.000917	CbGpPWpGaD
Rufinamide—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.84e-05	0.000914	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PTGER4—multiple sclerosis	8.83e-05	0.000913	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—TYK2—multiple sclerosis	8.79e-05	0.000909	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PGR—multiple sclerosis	8.7e-05	0.000899	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	8.58e-05	0.000888	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CXCR3—multiple sclerosis	8.53e-05	0.000882	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—CCL2—multiple sclerosis	8.5e-05	0.000878	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CD28—multiple sclerosis	8.45e-05	0.000874	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—TYK2—multiple sclerosis	8.45e-05	0.000874	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—TYK2—multiple sclerosis	8.45e-05	0.000874	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCR2—multiple sclerosis	8.3e-05	0.000858	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—TYK2—multiple sclerosis	8.15e-05	0.000842	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—TYK2—multiple sclerosis	8.15e-05	0.000842	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—TYK2—multiple sclerosis	8.11e-05	0.000839	CbGpPWpGaD
Rufinamide—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	8.05e-05	0.000832	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	7.92e-05	0.000819	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—MAPK1—multiple sclerosis	7.91e-05	0.000818	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—MMP9—multiple sclerosis	7.84e-05	0.00081	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—POMC—multiple sclerosis	7.79e-05	0.000805	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CNR1—multiple sclerosis	7.66e-05	0.000792	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	7.54e-05	0.00078	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	7.34e-05	0.000759	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—MMP9—multiple sclerosis	7.24e-05	0.000749	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—MAPK1—multiple sclerosis	7.24e-05	0.000748	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IFNG—multiple sclerosis	7.22e-05	0.000747	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—POMC—multiple sclerosis	7.07e-05	0.000731	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.05e-05	0.000728	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—MMP9—multiple sclerosis	6.98e-05	0.000722	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—STAT3—multiple sclerosis	6.97e-05	0.00072	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—MMP9—multiple sclerosis	6.93e-05	0.000716	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—CCL2—multiple sclerosis	6.92e-05	0.000716	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CXCL10—multiple sclerosis	6.89e-05	0.000713	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.89e-05	0.000712	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.89e-05	0.000712	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—IL6—multiple sclerosis	6.82e-05	0.000705	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	6.75e-05	0.000698	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—MMP9—multiple sclerosis	6.65e-05	0.000688	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—MMP9—multiple sclerosis	6.65e-05	0.000688	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TYK2—multiple sclerosis	6.56e-05	0.000678	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—TGFB1—multiple sclerosis	6.46e-05	0.000668	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IL1B—multiple sclerosis	6.44e-05	0.000666	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IL2—multiple sclerosis	6.42e-05	0.000664	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—MMP9—multiple sclerosis	6.42e-05	0.000663	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—MMP9—multiple sclerosis	6.42e-05	0.000663	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—MMP9—multiple sclerosis	6.39e-05	0.000661	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—MAPK1—multiple sclerosis	6.33e-05	0.000655	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—TYK2—multiple sclerosis	6.29e-05	0.00065	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TYK2—multiple sclerosis	6.28e-05	0.000649	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	6.23e-05	0.000644	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—STAT3—multiple sclerosis	6.21e-05	0.000642	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLEK—multiple sclerosis	6.17e-05	0.000638	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—IL6—multiple sclerosis	6.08e-05	0.000629	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—TNF—multiple sclerosis	6.03e-05	0.000624	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CD86—multiple sclerosis	6.03e-05	0.000623	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TYK2—multiple sclerosis	6.03e-05	0.000623	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TYK2—multiple sclerosis	6.03e-05	0.000623	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCL5—multiple sclerosis	5.94e-05	0.000614	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—MAPK1—multiple sclerosis	5.85e-05	0.000605	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TYK2—multiple sclerosis	5.81e-05	0.000601	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TYK2—multiple sclerosis	5.81e-05	0.000601	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—IL2—multiple sclerosis	5.76e-05	0.000595	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—TGFB1—multiple sclerosis	5.76e-05	0.000595	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	5.75e-05	0.000594	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	5.74e-05	0.000593	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—TYK2—multiple sclerosis	5.73e-05	0.000592	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—STAT3—multiple sclerosis	5.68e-05	0.000587	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—MAPK1—multiple sclerosis	5.65e-05	0.000584	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—MAPK1—multiple sclerosis	5.6e-05	0.000579	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—IL6—multiple sclerosis	5.56e-05	0.000575	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SPP1—multiple sclerosis	5.5e-05	0.000568	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—MAPK1—multiple sclerosis	5.38e-05	0.000556	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—MAPK1—multiple sclerosis	5.38e-05	0.000556	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—TNF—multiple sclerosis	5.38e-05	0.000556	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCR5—multiple sclerosis	5.35e-05	0.000553	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.34e-05	0.000552	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL2RA—multiple sclerosis	5.27e-05	0.000545	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—TGFB1—multiple sclerosis	5.27e-05	0.000544	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—IL2—multiple sclerosis	5.23e-05	0.000541	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—MAPK1—multiple sclerosis	5.19e-05	0.000536	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—MAPK1—multiple sclerosis	5.19e-05	0.000536	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—MMP9—multiple sclerosis	5.17e-05	0.000534	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—MAPK1—multiple sclerosis	5.16e-05	0.000534	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	5.12e-05	0.000529	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SRM—multiple sclerosis	5.07e-05	0.000524	CbGpPWpGaD
Rufinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.06e-05	0.000523	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	5.03e-05	0.00052	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—MMP9—multiple sclerosis	4.94e-05	0.000511	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—TNF—multiple sclerosis	4.92e-05	0.000508	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—IL6—multiple sclerosis	4.87e-05	0.000503	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—APOE—multiple sclerosis	4.86e-05	0.000503	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—MMP9—multiple sclerosis	4.75e-05	0.000491	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—MMP9—multiple sclerosis	4.75e-05	0.000491	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—POMC—multiple sclerosis	4.7e-05	0.000485	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—TNF—multiple sclerosis	4.68e-05	0.000483	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	4.64e-05	0.000479	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—STAT3—multiple sclerosis	4.59e-05	0.000475	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MMP9—multiple sclerosis	4.58e-05	0.000473	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—MMP9—multiple sclerosis	4.58e-05	0.000473	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MMP9—multiple sclerosis	4.51e-05	0.000466	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—IL6—multiple sclerosis	4.5e-05	0.000465	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CD80—multiple sclerosis	4.4e-05	0.000455	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—STAT3—multiple sclerosis	4.39e-05	0.000454	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SRM—multiple sclerosis	4.35e-05	0.00045	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SELE—multiple sclerosis	4.35e-05	0.000449	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—IL6—multiple sclerosis	4.34e-05	0.000449	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—IL6—multiple sclerosis	4.3e-05	0.000445	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—TGFB1—multiple sclerosis	4.29e-05	0.000444	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TGFB1—multiple sclerosis	4.26e-05	0.00044	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—STAT3—multiple sclerosis	4.22e-05	0.000436	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—STAT3—multiple sclerosis	4.22e-05	0.000436	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.22e-05	0.000436	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—POMC—multiple sclerosis	4.18e-05	0.000432	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—MAPK1—multiple sclerosis	4.18e-05	0.000432	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	4.16e-05	0.000431	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—IL6—multiple sclerosis	4.13e-05	0.000427	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—IL6—multiple sclerosis	4.13e-05	0.000427	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.1e-05	0.000424	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	4.09e-05	0.000423	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—CCL2—multiple sclerosis	4.09e-05	0.000423	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TYK2—multiple sclerosis	4.09e-05	0.000423	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TGFB1—multiple sclerosis	4.07e-05	0.000421	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—STAT3—multiple sclerosis	4.07e-05	0.000421	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—STAT3—multiple sclerosis	4.07e-05	0.000421	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—MAPK1—multiple sclerosis	4e-05	0.000414	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—MAPK1—multiple sclerosis	3.99e-05	0.000413	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—IL6—multiple sclerosis	3.98e-05	0.000412	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—IL6—multiple sclerosis	3.98e-05	0.000412	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—TNF—multiple sclerosis	3.98e-05	0.000411	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—IL6—multiple sclerosis	3.97e-05	0.00041	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TGFB1—multiple sclerosis	3.91e-05	0.000405	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TGFB1—multiple sclerosis	3.91e-05	0.000405	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—MAPK1—multiple sclerosis	3.84e-05	0.000397	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—MAPK1—multiple sclerosis	3.84e-05	0.000397	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—TNF—multiple sclerosis	3.8e-05	0.000393	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TGFB1—multiple sclerosis	3.77e-05	0.00039	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TGFB1—multiple sclerosis	3.77e-05	0.00039	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IL6—multiple sclerosis	3.77e-05	0.00039	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.73e-05	0.000386	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	3.71e-05	0.000384	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TYK2—multiple sclerosis	3.71e-05	0.000384	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—MAPK1—multiple sclerosis	3.7e-05	0.000383	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—MAPK1—multiple sclerosis	3.7e-05	0.000383	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—TNF—multiple sclerosis	3.65e-05	0.000378	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—TNF—multiple sclerosis	3.65e-05	0.000378	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—MAPK1—multiple sclerosis	3.65e-05	0.000377	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	3.57e-05	0.000369	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	3.57e-05	0.000369	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—TNF—multiple sclerosis	3.52e-05	0.000364	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—TNF—multiple sclerosis	3.52e-05	0.000364	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GPC5—multiple sclerosis	3.26e-05	0.000338	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MMP9—multiple sclerosis	3.22e-05	0.000333	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—IL6—multiple sclerosis	3.21e-05	0.000332	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—ITGA4—multiple sclerosis	3.14e-05	0.000325	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IFNB1—multiple sclerosis	3.12e-05	0.000322	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL2—multiple sclerosis	3.09e-05	0.000319	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—IL6—multiple sclerosis	3.07e-05	0.000318	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—IL6—multiple sclerosis	3.07e-05	0.000317	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP27B1—multiple sclerosis	3.07e-05	0.000317	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP24A1—multiple sclerosis	3.07e-05	0.000317	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3e-05	0.00031	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	3e-05	0.00031	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—IL6—multiple sclerosis	2.95e-05	0.000305	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—IL6—multiple sclerosis	2.95e-05	0.000305	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MMP9—multiple sclerosis	2.92e-05	0.000302	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—STAT3—multiple sclerosis	2.86e-05	0.000296	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—IL6—multiple sclerosis	2.84e-05	0.000294	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—IL6—multiple sclerosis	2.84e-05	0.000294	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GPC5—multiple sclerosis	2.81e-05	0.00029	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—IL6—multiple sclerosis	2.8e-05	0.00029	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—RRM1—multiple sclerosis	2.71e-05	0.00028	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TGFB1—multiple sclerosis	2.65e-05	0.000274	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—MAPK1—multiple sclerosis	2.6e-05	0.000269	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—STAT3—multiple sclerosis	2.6e-05	0.000269	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—TNF—multiple sclerosis	2.48e-05	0.000256	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	2.44e-05	0.000252	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MYC—multiple sclerosis	2.42e-05	0.00025	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TGFB1—multiple sclerosis	2.41e-05	0.000249	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—MAPK1—multiple sclerosis	2.36e-05	0.000244	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SRM—multiple sclerosis	2.35e-05	0.000243	CbGpPWpGaD
Rufinamide—ALB—Metabolism—RRM1—multiple sclerosis	2.32e-05	0.00024	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.18e-05	0.000225	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IL2RA—multiple sclerosis	2.15e-05	0.000222	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—IL6—multiple sclerosis	2e-05	0.000207	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.9e-05	0.000197	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.87e-05	0.000193	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL6—multiple sclerosis	1.82e-05	0.000188	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.8e-05	0.000186	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.66e-05	0.000171	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.66e-05	0.000171	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.55e-05	0.000161	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.55e-05	0.00016	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.51e-05	0.000157	CbGpPWpGaD
Rufinamide—ALB—Metabolism—BCHE—multiple sclerosis	1.34e-05	0.000138	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IL2—multiple sclerosis	1.26e-05	0.00013	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.26e-05	0.00013	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TGFB1—multiple sclerosis	9.81e-06	0.000101	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MAPK1—multiple sclerosis	9.63e-06	9.95e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—APOE—multiple sclerosis	9.35e-06	9.66e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—APOE—multiple sclerosis	8.03e-06	8.31e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—POMC—multiple sclerosis	8.03e-06	8.3e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALB—multiple sclerosis	7.32e-06	7.57e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.21e-06	7.45e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—POMC—multiple sclerosis	6.9e-06	7.14e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APOE—multiple sclerosis	4.34e-06	4.48e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—POMC—multiple sclerosis	3.73e-06	3.85e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALB—multiple sclerosis	3.4e-06	3.51e-05	CbGpPWpGaD
